Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Obstetric complications and psychopathology in schizophrenia: A systematic review and meta-analysis

  • Forte, Maria Florencia
  • Oliva, Vincenzo
  • De Prisco, Michele
  • Garriga, Marina
  • Bitanihirwe, Byron
  • Alameda, Luis
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Obstetric complications; Psychopathology; Schizophrenia, Complicaciones obstétricas; Psicopatología; Esquizofrenia, Complicacions obstètriques; Psicopatologia; Esquizofrènia, Schizophrenia (SZ) is a severe mental health condition involving gene-environment interactions, with obstetric complications (OCs) conferring an elevated risk for the disease. Current research suggests that OCs may exacerbate SZ symptoms. This study conducted a systematic review and meta-analysis to comprehensively evaluate differences in psychopathology between individuals with and without exposure to OCs in relation to SZ and related disorders. We systematically searched PubMed, PsycINFO, and SCOPUS to identify eligible studies. A total of 4091 records were retrieved through systematic and citation searches. 14 studies were included in the review, and 12 met the criteria for meta-analysis, involving 2992 patients. The analysis revealed that SZ patients who had been exposed to OCs exhibited significantly higher levels of positive symptoms (SMD=0.10, 95 %CI=0.01,0.20; p=0.03), general psychopathology (SMD=0.37, 95 %CI=0.22,0.52; p<0.001), total clinical symptomatology (SMD=0.44, 95 %CI=0.24,0.64; p<0.001) and depressive symptoms (SMD=0.47, 95 %CI=0.09,0.84; p=0.01). No significant differences were found in negative symptomatology and functioning. Our results suggest that OCs are not only associated with an increased risk of developing psychosis but with more severe symptomatology., This study is part of the project PI20/00661 (C. García-Rizo) and PI24/00196 (C. Garcia-Rizo and G. Mezquida) funded by the Carlos III Health Institute (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, CERCA Program / Generalitat de Catalunya And Secretaria d′Universitats i Recerca del Departament d′Economia I Coneixement (2017SGR1355). G. Mezquida is a Serra Húnter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212–024, Generalitat de Catalunya). M. F. Forte received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union NextGenerationEU. S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016–2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. M. Garriga thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI21/00340) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358). CERCA Programme/Generalitat de Catalunya. J.A. Ramos-Quiroga thanks the suport of the CIBERSAM; Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Psychiatry, Mental Health and Addictions Group (2021 SGR 00840). I. Baeza thanks the Spanish Ministry of Science, Innovation and Universities and Instituto de Salud Carlos III (PI21/0391) co-funded by the European Union, the National Drugs Plan (2022 I053) and Fundación Alicia Koplowitz., We would like to thank the Carlos III Healthcare Institute, the Spanish Ministry of Science, Innovation and Universities, the European Regional Development Fund (ERDF/FEDER) (PI08/0208, PI11/00325, PI14/00612, PI14/00753, PI20/00661, and PI24/00196); CIBERSAM; CERCA Program; Government of Catalonia, the Secretariat of Universities and Research of the Department of Enterprise and Knowledge (2021 SGR 01120), the Institut de Neurociències, Universitat de Barcelona, UBNeuro, and the Serra-Hunter Programme, Government of Catalonia. This work was also supported by La Marató-TV3 Foundation grants 202234–32 (to S. Amoretti); 202234–30 (to E. Vieta); 202234–30 (to A. Gonzàlez-Segura), 202225–30 (to R. Penadés). IB thanks Pons Bartran legacy (FCRB_IPB2–2023), and CGR thanks the Maria i Nuria Cunillera legacy (FCRB_CU1_2024) for the support.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Mezquida Mateos, Gisela
  • Sánchez-Torres, Ana Maria
  • Serra-Navarro, Maria
  • Penadés , Rafael
  • Forte, Maria Florencia
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Emotional intelligence; Emotional processing; Neurocognition, Inteligencia emocional; Procesamiento emocional; Neurocognición, Intel·ligència emocional; Processament emocional; Neurocognició, Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, by the CERCA Programme / Generalitat de Catalunya AND Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2021 SGR 01120). Departament de Salut de la Generalitat de Catalunya, en la convocatòria corresponent a l'any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345. This work was supported by La Marató-TV3 Foundation grants 202234-30 (to E. Vieta), 202234-32 (to S. Amoretti). S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. MFF received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union – tGenerationEU. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. A. González-Pinto thanks the support of the Spanish Ministry of Science, Innovation and Universities PI21/00713, PI18/01055 integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Basque Government 2022111054. C. Torrent thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI20/00344) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Sex differences in the efficacy of cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder

  • Biel, Santiago
  • Mestres-Ferrés, Ferran
  • Ramos Sayalero, Carolina
  • Fadeuilhe, Christian
  • Crespín Hombrao, Juan Jesús
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Parramon Puig, Gemma
  • Ibáñez-Jiménez, Pol
  • Nieva, Gemma
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
ADHD; Cognitive behavioral therapy; Sex differences, TDAH; Teràpia cognitivo-conductual; Diferències sexuals, TDAH; Terapia cognitivo-conductual; Diferencias sexuals, Background and objectives Cognitive Behavioral Therapy (CBT) is an effective adjunctive treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). This study examined sex differences in the efficacy of a brief 6-session CBT program versus a traditional 12-session format, combined with stable pharmacotherapy, in adults with ADHD. Methods A total of 81 adults (58 % male; 41.27 ± 9.26 years) were randomly assigned to 6- or 12-session CBT. ADHD symptoms, psychopathology, and functioning were assessed at baseline, post-treatment, and 3- and 6-month follow-up. Mixed-effects models analyzed interactions between time, treatment group, and sex. Results At baseline, females exhibited greater symptom severity (p = 0.019), higher inattention (p < 0.001), and more pronounced impairments (p = 0.004). CBT led to significant clinical improvements regardless of sex. A significant time-by-sex interaction emerged for inattention (CAARS:O:L, p = 0.043), although it did not remain significant after adjusting for baseline severity. Regarding time × group × sex interactions, females in the 6-session group showed smaller reductions in clinical severity during follow-up (CGI-S, p = 0.047); however, this effect was no longer statistically significant after controlling for baseline ADHD severity. Findings should be interpreted with caution given the limited female sample at follow-up and the significant influence of initial symptom burden on long-term trajectories. Conclusions CBT improves ADHD symptoms and related impairments in adults, with comparable overall benefits across sexes. Treatment response follow-up differences were better explained by baseline severity and treatment intensity rather than sex-specific differences., This research was supported by the Generalitat de Catalunya, Departament de Recerca i Universitats, through the Comissionat per a Universitats i Recerca (SGR grant 2021 SGR 00840). Dr. Amoretti (PI24/00671) and Dr. Torrent (PI20/00344; PI24/00407) thank the support of the Spanish Ministry of Innovation and Science, funded by the Instituto de Salud Carlos III and cofinanced by the European Union (FEDER) “Una manera de hacer Europa”. Dr. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future” and La Marató-TV3 Foundation grants 202234-32. Dr. Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

  • Clougher, Derek
  • Mezquida Mateos, Gisela
  • Sánchez-Torres, Ana Maria
  • Serra-Navarro, Maria
  • Penadés , Rafael
  • Forte, Maria Florencia
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Emotional intelligence; Emotional processing; Neurocognition, Inteligencia emocional; Procesamiento emocional; Neurocognición, Intel·ligència emocional; Processament emocional; Neurocognició, Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles in EI and NC performance in FEP. 98 adult FEP patients and 128 healthy controls (HCs) were tested on clinical, functional, EI, and NC variables at baseline and two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients and HCs) and time on EI. Significant EI improvements were observed in both groups. Four groups were created based on NC and EI performance at baseline and FUP in patients: impairment in NC and EI, impairment in NC only, impairment in EI only, and no impairment. At FUP, patients impaired in NC and EI showed less cognitive reserve (CR), greater negative and positive symptoms, and poorer functional outcomes. At FUP, three group trajectories were identified: (I) maintain dual impairment (II) maintain no impairment or improve, (III) maintain sole impairment or worsen. The maintain dual impairment group had the lowest levels of CR. EI and NC impairments progress differently in FEP. Greater CR may protect against comorbid EI/NC impairment. Identifying these patient characteristics could contribute to the development of personalised interventions., This study is part of a coordinated-multicentre Project, funded by the Ministerio de Economía y Competitividad (PI08/0208; PI11/00325; PI14/00612), Instituto de Salud Carlos III – Fondo Europeo de Desarrollo Regional. Unión Europea. Una manera de hacer Europa, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, by the CERCA Programme / Generalitat de Catalunya AND Secretaria d'Universitats i Recerca del Departament d'Economia I Coneixement (2021 SGR 01120). Departament de Salut de la Generalitat de Catalunya, en la convocatòria corresponent a l'any 2017 de concessió de subvencions del Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020, modalitat Projectes de recerca orientats a l'atenció primària, amb el codi d'expedient SLT006/17/00345. This work was supported by La Marató-TV3 Foundation grants 202234-30 (to E. Vieta), 202234-32 (to S. Amoretti). S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. MFF received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union – tGenerationEU. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016-2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. A. González-Pinto thanks the support of the Spanish Ministry of Science, Innovation and Universities PI21/00713, PI18/01055 integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Basque Government 2022111054. C. Torrent thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI20/00344) integrated into the Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Sex differences in the efficacy of cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder

  • Biel, Santiago
  • Mestres-Ferrés, Ferran
  • Ramos Sayalero, Carolina
  • Fadeuilhe, Christian
  • Crespín Hombrao, Juan Jesús
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Parramon Puig, Gemma
  • Ibáñez-Jiménez, Pol
  • Nieva, Gemma
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
ADHD; Cognitive behavioral therapy; Sex differences, TDAH; Teràpia cognitivo-conductual; Diferències sexuals, TDAH; Terapia cognitivo-conductual; Diferencias sexuals, Background and objectives Cognitive Behavioral Therapy (CBT) is an effective adjunctive treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). This study examined sex differences in the efficacy of a brief 6-session CBT program versus a traditional 12-session format, combined with stable pharmacotherapy, in adults with ADHD. Methods A total of 81 adults (58 % male; 41.27 ± 9.26 years) were randomly assigned to 6- or 12-session CBT. ADHD symptoms, psychopathology, and functioning were assessed at baseline, post-treatment, and 3- and 6-month follow-up. Mixed-effects models analyzed interactions between time, treatment group, and sex. Results At baseline, females exhibited greater symptom severity (p = 0.019), higher inattention (p < 0.001), and more pronounced impairments (p = 0.004). CBT led to significant clinical improvements regardless of sex. A significant time-by-sex interaction emerged for inattention (CAARS:O:L, p = 0.043), although it did not remain significant after adjusting for baseline severity. Regarding time × group × sex interactions, females in the 6-session group showed smaller reductions in clinical severity during follow-up (CGI-S, p = 0.047); however, this effect was no longer statistically significant after controlling for baseline ADHD severity. Findings should be interpreted with caution given the limited female sample at follow-up and the significant influence of initial symptom burden on long-term trajectories. Conclusions CBT improves ADHD symptoms and related impairments in adults, with comparable overall benefits across sexes. Treatment response follow-up differences were better explained by baseline severity and treatment intensity rather than sex-specific differences., This research was supported by the Generalitat de Catalunya, Departament de Recerca i Universitats, through the Comissionat per a Universitats i Recerca (SGR grant 2021 SGR 00840). Dr. Amoretti (PI24/00671) and Dr. Torrent (PI20/00344; PI24/00407) thank the support of the Spanish Ministry of Innovation and Science, funded by the Instituto de Salud Carlos III and cofinanced by the European Union (FEDER) “Una manera de hacer Europa”. Dr. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future” and La Marató-TV3 Foundation grants 202234-32. Dr. Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Obstetric complications and psychopathology in schizophrenia: A systematic review and meta-analysis

  • Forte, Maria Florencia
  • Oliva, Vincenzo
  • De Prisco, Michele
  • Garriga, Marina
  • Bitanihirwe, Byron
  • Alameda, Luis
  • Amoretti, Silvia
  • Ramos-Quiroga, Josep Antoni
Obstetric complications; Psychopathology; Schizophrenia, Complicaciones obstétricas; Psicopatología; Esquizofrenia, Complicacions obstètriques; Psicopatologia; Esquizofrènia, Schizophrenia (SZ) is a severe mental health condition involving gene-environment interactions, with obstetric complications (OCs) conferring an elevated risk for the disease. Current research suggests that OCs may exacerbate SZ symptoms. This study conducted a systematic review and meta-analysis to comprehensively evaluate differences in psychopathology between individuals with and without exposure to OCs in relation to SZ and related disorders. We systematically searched PubMed, PsycINFO, and SCOPUS to identify eligible studies. A total of 4091 records were retrieved through systematic and citation searches. 14 studies were included in the review, and 12 met the criteria for meta-analysis, involving 2992 patients. The analysis revealed that SZ patients who had been exposed to OCs exhibited significantly higher levels of positive symptoms (SMD=0.10, 95 %CI=0.01,0.20; p=0.03), general psychopathology (SMD=0.37, 95 %CI=0.22,0.52; p<0.001), total clinical symptomatology (SMD=0.44, 95 %CI=0.24,0.64; p<0.001) and depressive symptoms (SMD=0.47, 95 %CI=0.09,0.84; p=0.01). No significant differences were found in negative symptomatology and functioning. Our results suggest that OCs are not only associated with an increased risk of developing psychosis but with more severe symptomatology., This study is part of the project PI20/00661 (C. García-Rizo) and PI24/00196 (C. Garcia-Rizo and G. Mezquida) funded by the Carlos III Health Institute (ISCIII) and co-financed by the European Union, Centro de Investigación Biomédica en Red de salud Mental, CIBERSAM, CERCA Program / Generalitat de Catalunya And Secretaria d′Universitats i Recerca del Departament d′Economia I Coneixement (2017SGR1355). G. Mezquida is a Serra Húnter Fellow, within the Tenure-elegible Lecturer Serra Hunter program (UB-LE-212–024, Generalitat de Catalunya). M. F. Forte received the support of “Contratos predoctorales de formación en investigación en salud" (PFIS22) (FI22/00185) from the Instituto de Salud Carlos III (ISCIII) with European funds from the Recovery, Transformation and Resilience Plan, by virtue of the Resolution of the Directorate of the Carlos III Health Institute, O.A., M.P. of December 14, 2022, granting Predoctoral Research Training Contracts in Health (PFIS Contracts). Funded by the European Union NextGenerationEU. S. Amoretti has been supported by Sara Borrell doctoral programme (CD20/00177) and M-AES mobility fellowship (MV22/00002), from the Instituto de Salud Carlos III (ISCIII), and co-funded by European Social Fund “Investing in your future”. E. Vieta thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI18/00805; PI21/00787) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358) and the project SLT006/17/00357, from PERIS 2016–2020 (Departament de Salut). CERCA Programme/Generalitat de Catalunya. M. Garriga thanks the support of the Spanish Ministry of Science, Innovation and Universities (PI21/00340) integrated into the Plan Nacional de I+D+I and co-financed by ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER); CIBERSAM; and the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Bipolar Disorders Group (2021 SGR 1358). CERCA Programme/Generalitat de Catalunya. J.A. Ramos-Quiroga thanks the suport of the CIBERSAM; Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya to the Psychiatry, Mental Health and Addictions Group (2021 SGR 00840). I. Baeza thanks the Spanish Ministry of Science, Innovation and Universities and Instituto de Salud Carlos III (PI21/0391) co-funded by the European Union, the National Drugs Plan (2022 I053) and Fundación Alicia Koplowitz., We would like to thank the Carlos III Healthcare Institute, the Spanish Ministry of Science, Innovation and Universities, the European Regional Development Fund (ERDF/FEDER) (PI08/0208, PI11/00325, PI14/00612, PI14/00753, PI20/00661, and PI24/00196); CIBERSAM; CERCA Program; Government of Catalonia, the Secretariat of Universities and Research of the Department of Enterprise and Knowledge (2021 SGR 01120), the Institut de Neurociències, Universitat de Barcelona, UBNeuro, and the Serra-Hunter Programme, Government of Catalonia. This work was also supported by La Marató-TV3 Foundation grants 202234–32 (to S. Amoretti); 202234–30 (to E. Vieta); 202234–30 (to A. Gonzàlez-Segura), 202225–30 (to R. Penadés). IB thanks Pons Bartran legacy (FCRB_IPB2–2023), and CGR thanks the Maria i Nuria Cunillera legacy (FCRB_CU1_2024) for the support.